NCT07217522 - Rutgers University Study of the Genetics of Pulmonary Hypertension | Biotech Hunter

Enrollment

10,000

Participants

Timeline

Start Date

August 23, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Pulmonary HypertensionPulmonary Arterial HypertensionPulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)Pulmonary Arterial Hypertension Associated With Connective Tissue DiseasePulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder)Pulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder)Pulmonary Arterial Hypertension of Congenital Heart DiseasePulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension

Interventions

GENETIC

Saliva sample

Saliva sample is sent via prepaid US Mail for DNA extraction

OTHER

Health surveys

Health surveys are filled out online in the study portal.

Trial Locations (1)

08854

RECRUITING

Rutgers University, Piscataway, New Jersey 08854, Piscataway

All Listed Sponsors

lead

Rutgers, The State University of New Jersey

OTHER